Orion is a globally operating Finnish pharmaceutical company - a builder of well-being.
About OrionStock exchange releases
- 12/4/2023 87 000 Orion Corporation A shares converted into B shares
- 10/26/2023 Orion Group Interim Report January–September 2023
- 9/20/2023 Change in Orion Group's Half-Year Financial Report 2024 publication date
- 9/4/2023 24 000 Orion Corporation A shares converted into B shares
Press releases
- 11/21/2023 Phase 3 Clinical Trials with ODM-208 (MK-5684) posted to ClinicalTrials.gov database
- 11/20/2023 Orion Animal Health receives FDA approval for Bonqat® (pregabalin oral solution)
- 11/15/2023 Orion Research Foundation grants EUR 1,112,000 for research in 2024
- 10/16/2023 Orion publishes Interim Report for January–September 2023 on Thursday 26 October 2023
Latest articles
All articles
Sharing of information helps in the development of new medicines...
12/1/2023
Sustainability
Through an apprenticeship, Christina Holappa qualified as a labo...
11/22/2023
We are Orion
Why don’t people take their prescribed medicines as directed?
11/17/2023
Your Health
Having seizures is often only one part of epilepsy
11/14/2023
Your Health
An assistant is a magician working in the background, whose expe...
11/9/2023
We are Orion
